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Studies of tyrosine phosphorylation in the human duodenum have indicated that proliferating cells in the middle portion of the
duodenal crypt were devoid of this feature, suggesting that tyrosine kinase activation is not a dominant factor in crypt cell prolifer-
ation, and that consequently tyrosine phosphatase activity may be a more critical factor in crypt cell development. We investigated
the expression of the leukocyte common antigen-related receptor (LAR) family of tyrosine phosphatases. A ﬂow cytometry system
was used to examine cells from the surface, mid-portion, and lower part of the crypt. Individual cell populations were immunos-
tained with anti-LAR antibodies using phycoerythrin-conjugated anti-CD3 to discriminate between epithelial cells (CD3−)a n d
intraepithelial lymphocytes (CD3+). Epithelial cells expressed LAR throughout the crypt. Expression of LAR was maximal in the
mid-portion of the crypt with lower expression at the top of the villi. Intraepithelial lymphocytes expressed low levels of LAR at
the tips of the villi with stronger expression extending towards the base of the crypt. These ﬁndings were conﬁrmed by immuno-
histochemistry on paraﬃn-ﬁxed sections. Of note, peripheral blood lymphocytes expressed less LAR than IEL. These observations
suggest the possibility that tyrosine phosphatase LAR may be of importance in the regulation of crypt cell proliferation. Moreover,
as the extracellular domain of LAR has homology with adhesion molecules, the ﬁnding of this molecule on IEL could suggest a
possible functional role in homing of this unique lymphocyte.
INTRODUCTION
Protein tyrosine phosphatases (PTPases) comprise
a structurally diverse family of transmembrane and
cytoplasmic-type enzymes that, together with protein ty-
rosine kinases (PTKases) control protein tyrosine phos-
phorylation [1]. Tyrosine phosphorylation is known to
regulate such physiological events as cell-cell, and cell-
matrix interactions and is associated with many cellu-
lar processes including activation, proliferation, diﬀeren-
tiation, and migration [2, 3, 4]. The human transmem-
brane molecule leukocyte common antigen-related re-
ceptor (LAR) is part of a family of receptor protein ty-
rosine phosphatases, of which there are approximately
20 known members. It has structural features similar to
the extracellular receptor region of the immunoglobulin
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superfamily of adhesion molecules, and the ﬁbronectin
type-III like repeats in the same region of the neural cell
adhesion molecule 1 (N-CAM-1) [5, 6]. The cytoplas-
mic segment of LAR consists of either one or two tan-
dem phosphatase domains with a single transmembrane
region [7]. Thus, LAR which is part of a distinct class
of proteins might be involved in cell adhesive interac-
tions as well as having tyrosine phosphorylation function
[8].
The cytoplasmic domain of LAR is also similar to the
leukocyte common antigen (LCA), CD45 (also known as
T200 B220, and Ly-5), the prototype and ﬁrst discovered
receptor-linked protein tyrosine phosphatase [9]. CD45
is a high-molecular-weight glycoprotein, exclusively re-
stricted to leukocytes, including intraepithelial lympho-
cytes (IEL) [1, 10]. CD45 tyrosine phosphatase appears to
be required for the coupling of T-cell antigen receptor sig-
nals to the phosphoinositol second messenger signal and
mayalsoparticipateintherapidincreaseintyrosinephos-
phorylation induced by activation of the T cell receptor
[11, 12]. It has been shown that both LCA and LAR have
phosphatase activity in vitro [13, 14].24 Anne M. Murphy et al 2005:1 (2005)
The diversity in the extracellular region of LAR pre-
sumably reﬂects a diversity of ligands to which this en-
zyme responds. The identity of a ligand for CD45 is still
not clear. It has been shown that heparin sulphate on
bone marrow stromal cells serves as a ligand for CD45,
while CD22 has been shown to be the molecule on B
cells [15, 16]. To date, little is known about the ligand
for LAR although homotypic interactions have been re-
ported. LAR may associate with the actin cytoskeleton
through cadherins or catenin molecules [17]. It is also
possible that LAR which is expressed in many tissues and
cell types may act by modulating phosphorylation of the
components of the signal pathways that regulate cell ad-
hesion [18].
Until recently, protein phosphatases have played a low
proﬁle in the protein phosphorylation ﬁeld. However, it
is clear that protein phosphatases do not simply consti-
tutively reverse the eﬀects of protein kinases but rather
play a speciﬁc role in cellular biology [19]. Studies using
knock-out mice have demonstrated that intestinal crypts
can develop in the absence of the epidermal growth factor
(EGF), a tyrosine kinase receptor [20].
Furthermore, studies of tyrosine phosphorylation in
the human duodenum have indicated that proliferating
cells in the middle and lower portions of the duode-
nal crypt were devoid of tyrosine phosphorylation [21].
These data indicate that tyrosine kinase activation me-
diated by EGF is not necessarily a dominant factor in
crypt cell proliferation and suggest that tyrosine phos-
phatase activity may be a more critical factor in crypt de-
velopment. Lastly, it has been reported that cellular lev-
els of tyrosine kinase activity is downregulated in colon
cancer suggesting a possible correlation with colonic tu-
mor growth, while structures similar to the extracellular
domain of LAR have been reported in the colon-cancer-
associated gene DCC [22, 23].
Antibodies totheLARreceptorproteintyrosinephos-
phatase (RPTP) have made it possible to study the expres-
sion of LAR in diﬀerent tissues and in single-cell suspen-
sions [5, 6]. We therefore investigated the expression of
this family of molecules in the human duodenal crypt. A
system was devised using two-colour ﬂow cytometry to
assay the sequential elution of intraepithelial lymphocytes
(CD3+) and epithelial cells (CD3−) from the upper, mid-
dle, and lower regions of the human duodenal crypt. We
determined the level of expression of LAR in IEL and ep-
ithelial cells in the duodenal crypt. In addition, we con-
ﬁrmed the speciﬁc location of LAR within the duodenal




Duodenal biopsy specimens were obtained endoscop-
ically from patients giving informed consent. Four biopsy
fragments were taken from each patient. These patients
were receiving treatment for dyspeptic symptoms and
were all found to have a normal small intestine on his-
tological examination. The Ethics Committee of the Fed-
erated Dublin Voluntary Hospital approved protocols for
the use of duodenal biopsy tissue.
Flowcytometricanalysisof
enterocyteLARexpression
LAR expression was measured by indirect immuno-
ﬂuorescence and ﬂow cytometry. A mixed population of
IEL and epithelial cells was removed from biopsy tis-
sue by sequential elution over periods of 30, 60, 90, and
120 minutes, using a method previously described [24].
Brieﬂy, specimens were incubated in a solution of 1mM
EDTA and 1mM DTT in Ca2+ and Mg2+ free Hanks
buﬀered saline solution. Cells were harvested, counted
a n da d j u s t e dt o1 0 6 cells/mL. They were incubated for
15minutes in 2%(v/v) paraformaldehyde and washed
twice in a solution of phosphated buﬀered saline contain-
ing 0.01%(v/v) bovine serum albumin, and 0.01%(v/v)
sodium azide (PBS/BSA/NaN3), henceforth used in all
subsequent washes. Cells were incubated with an aﬃn-
ity puriﬁed polyclonal antibody to the E-subunit of the
LAR molecule, rabbit anti-LAR (Transduction Laborato-
ries, Lexington, Ky), for 30minutes at a concentration of
0.1µ g/mL. The antibody, though not tested for cross-
reactivity with other isoforms of LAR, should recognise
any LAR proteins containing the E-subunit. A control
polyclonal antibody, anti-keyhole limpet haemocyanin
(KLH), (Sigma, St Louis, Mo), was also used and cells
were incubated for 30 minutes with a control antibody
at concentration 0.1µ g/mL. The cells were then washed
twice with PBS solution. Samples were reincubated with
a ﬂuorescein-conjugated goat anti-rabbit secondary an-
tibody (Dakopatts, Glostrop, Denmark) for a further
30minutes, and again washed twice with PBS solution.
Normal rabbit serum was used to block nonspeciﬁc bind-
ing sites, for 10minutes. Samples were again washed
twice with PBS and ﬁnally incubated for 10minutes
with an anti-CD3 monoclonal antibody directly con-
jugated to phycoerythrin (Becton Dickinson, Mountain
View, Calif). Two-colour ﬂow cytometric analysis was
performed using the Becton-Dickinson FACScan with
Lysys 11 software. The CD3+ and CD3− cell populations
were identiﬁed by gating on forward scatter (FSC) against
FL2/PE, (CD3+) showing histograms of FL1 positivity for
LAR and KLH.
Immunohistochemistry
Paraﬃn-embedded sections were cut from duodenal
biopsy tissue, showing clearly the upper, middle, and
lower parts of the duodenal crypts. Pellets were pre-
pared from a human umbilical vein endothelial cell (HU-
VEC) line, and paraﬃn-embedded sections cut to use
as a positive control for LAR staining. Sections were
then mounted on APS (3-aminopropyltriethoxysilane)
slides and left overnight at 55◦C. Sections were ﬁxed in2005:1 (2005) Tyrosine Phosphatase Expression in the Human Duodenum 25














































Figure 1. Flow cytometric histogram proﬁles of LAR expression in (a) unﬁxed human umbilical vein endothelial cells (HUVEC) and
(b) ﬁxed HUVEC. The shaded proﬁle represents the expression obtained with the isotype control antibody, anti-KLH, and the open
proﬁle represents the expression with an anti-LAR antibody. These results are representative of three experiments. MFI denotes mean
ﬂurescence identity.
methanol/acetonefor10minutesfollowedbydewaxingin
xylene and alcohol. Endogenous peroxidase was blocked
by incubating sections in a solution of 0.3% H2O2 in
methanol for 30minutes. After washing in H2O followed
by a Tris buﬀered saline (TBS) wash, the samples were
microwaved at 800 W in 10mM citrate buﬀer, pH 6, for
20 minutes as previously described [25]. Sections were
blocked with 1.0% bovine serum albumin for 10minutes.
The LAR antibody was applied and incubated at 4◦C
overnight, followed by two TBS washes. Sections were
incubated in a biotinylated antirabbit second antibody
(Amersham, Buckingham, UK) for 60minutes at room
temperature and, following two TBS washes, were incu-
bated in ABC Elite solution (Vectastatin, Vector Labo-
ratories, Burlington, Calif) for 30minutes in a humid-
iﬁed chamber. Finally, sections were stained with di-
aminobenzidine tetrahydrochloride (DAB) solution for
7minutes counterstained in haematoxylin (5seconds),
and mounted in DPX (distyrene tricresylephosphate xy-
lene mountant for Microscopy, 360294H), BDH, Poole,
England. Photographs were taken with a Nikon camera
mounted on a Polyvar 2 Reichart Jung light microscope.
RESULTS
FACScanproﬁlesshow LARexpression inunﬁxedand
ﬁxed HUVECs (Figures 1a and 1b) .T h e r ei sl e s sL A Re x -
pression detected in unﬁxed cells in comparison to that
detected in ﬁxed cells suggesting that the LAR molecule
may be shed in unﬁxed cells. This is consistent with pre-
vious ﬁndings that LAR is shed [26, 27]. Histograms
of IEL CD3+ (positive) and epithelial CD3− (negative)
enterocyte cell populations, eluted after 30, 60, 90, and
120minutes intervals following EDTA/DTT incubation
show diﬀerential expression of LAR in IEL CD3+ cells
(Figures 2a, 2c, 2e,a n d2g) and in epithelial CD3− cells
(Figures 2b, 2d, 2f,a n d2h). The 30-minute incubation
with EDTA/DTT removes surface enterocytes from the
tips of villi. This is an area where the cells are more dif-
ferentiated and fewer IEL are extracted [21]. It is evident
from Figure 2c that the phosphatase molecule LAR is sig-
niﬁcantly expressed in CD3+ intraepithelial lymphocytes,
isolated after 60minutes. This corresponds to the upper
and middle portions of the crypt [21]. Cells in the middle
andlowerportionsofthecryptaremorelikelytoundergo
proliferation. LAR is expressed in the CD3− cell popula-
tion at higher levels in the upper, middle, and lower por-
tions of the crypts where cellular proliferation is more
likely to occur (Figures 2b, 2d, 2f,a n d2h)[ 28, 29]. LAR
is also expressed in peripheral blood lymphocytes (Figure
3a), but expression is low in comparison with IEL (Figure
3b).
Intraepithelial lymphocytes intercalate between the
epithelial cells of the villi and crypts. Under high power
(×400) they can be detected in the upper, middle and
lowerareasofthevilli.LARstainingispresentinIELatthe
tips of the villi (Figures 4a and 4b), while there was strong
staining evident in IEL at the base of the crypt (Figures 4a
and 4c). A black arrow indicates the IEL. LAR expression
was also detected within the duodenal lamina propia lym-
phocytes. Closer examination of the pattern of expression
of LAR staining within the cells suggests a predominantly
surfacepattern.ThisisconﬁrmedbythefactthatLARwas
detected by surface staining and ﬂow cytometry in non-
permeabilized cells. Finally, similar surface expression is
seen in control HUVECs (Figure 4d). The negative con-
trol KLH staining is seen in duodenal biopsy tissue (Fig-
ure 4e).26 Anne M. Murphy et al 2005:1 (2005)








































































































































































































Figure 2. Flow cytometric histogram proﬁles of LAR expression in (a), (c), (e), (g) CD3+ (positive) cells and (b), (d), (f), (h) CD3−
(negative) cells, reﬂecting isolation periods, 30, 60, 90, and 120 minutes. The shaded histograms on CD3+ and CD3− cell populations
represent the expression of the anti-KLH antibody, and the open histograms in the CD3+ and CD3− cell populations represent the
expression obtained with the anti-LAR antibody. Note: anti-KLH and anti-LAR expressions in the CD3+ cells have moved from 0 to
50 on the forward scatter axis (g). Nonspeciﬁc uptake of the antibody due to the length of incubation, or a population of lymphocytes
with diﬀerent phenotypic characteristics may explain this result. These results are representative of three experiments. MFI denotes
mean ﬂuorescence identity.2005:1 (2005) Tyrosine Phosphatase Expression in the Human Duodenum 27














































Figure 3. Flow cytometric histogram proﬁles showing LAR expression in (a) peripheral blood lymphocytes (PBL), and (b) intraep-
ithelial lymphocytes (IEL). The shaded histograms represent the expression obtained with the isotype control antibody, anti-KLH,
and the open histograms represent the expression obtained with the anti-LAR antibody. These results are representative of three
experiments. MFI denotes mean ﬂuorescence indentity.
DISCUSSION
In this study we have developed a two-colour ﬂow cy-
tometric method for the detection of the tyrosine phos-
phatase LAR on epithelial cells and IEL eluted from en-
doscopically obtained duodenal biopsy tissue. We have
shown that LAR is expressed in CD3 negative epithelial
cells in the upper, middle, and lower regions of the duo-
denal crypts. It has been shown that the middle and lower
regions of the crypts are areas of cellular proliferation and
that low levels of tyrosine phosphorylation have been de-
tected in the epithelial cells in these areas [21, 28]. Al-
though there is no doubt that EGF can cause intestinal
epithelialcellularproliferation,thereisemergingevidence
that this is not its only function within the gastrointesti-
nal tract [30]. It is also reported that crypt villi can grow
in the absence of EGF receptor, a tyrosine kinase recep-
tor molecule [20]. In addition, LAR gene products were
detected to be abundantly expressed in rat oesophagus,
skin, and small intestine, all of which are areas of con-
tinuously renewable epithelia [31]. These ﬁndings sug-
gest that molecules other than tyrosine kinases may have
a greater role to play in crypt cell proliferation. Tyrosine
phosphatases, which cleave phosphate groups from tyro-
sine residues, may be the relevant molecules involved in
crypt epithelial proliferation. The LAR family of tyrosine
phosphatases may play an active role [32].
We have also shown LAR to be expressed in CD3 pos-
itive IEL eluted at 60 minutes in EDTA/DTT. These are
a highly specialised subpopulation of T lymphocytes re-
stricted to the mucosal epithelia. They diﬀer from T cells
in other lymphoid organs in that they are predominantly
CD3+CD8+. The integrin αEβ7 is highly expressed in
these cells and it has been hypothesised that IEL pos-
sess speciﬁc receptors enabling interaction with local lig-
ands and controlling homing to and migration through
basement membrane [33]. It is thought that adhesion
molecules may play a major role, but the mechanism by
which IEL rapidly migrate to sites of inﬂammation is not
fully understood. The expression of LAR in a signiﬁcant
subpopulation of IEL suggests a role in the homing of this
unique population to distinct sites in the gut mucosa. The
extracellular domain of LAR has homology with adhesion
molecules,forexampleN-CAM,suggestingapossiblerole
in IEL enterocyte interactions [17]. As LAR interacts ho-
motypically, LAR-LAR interactions between IEL and ep-
ithelial cells could represent one mechanism by which IEL
epithelial cell interactions occur. Further deﬁnition of the
phenotype of LAR positive IEL subpopulations should
provideimportantinsightintothemechanismsofIELmi-
gration.
It has been shown that LAR is expressed in the cell
surface as a complex of two noncovalently associated sub-
units. LAR E-subunit contain the cell adhesion molecule
receptor region, and the LAR P-subunit contain a short
segment of extracellular, transmembrane, and cytoplas-
mic domains. The LAR cell adhesion molecule E-subunit
is shed during cell growth, suggesting that receptor shed-
ding may be an important mechanism for regulating PT-
Pase function [26, 27]. The apparent loss of LAR expres-
sion in the CD3 positive cell population at the tips of
the villi could reﬂect simply loss of the E-subunit. Hence,
the shedding of LAR E-subunit might reduce the respon-
siveness of LAR to a cognate ligand. The LAR (PTPase)
and LAR interacting protein 1 (LIP.1) have been shown
to colocalise at focal adhesions suggesting that LAR and
LIP.1 may regulate the disassembly of focal adhesions and
thus regulate cell-cell, cell matrix interactions and migra-
tion, by facilitating the recruitment of LAR to cytoskeletal
targets. They may also regulate LAR extracellular matrix
interactions, retaining LAR at the cell surface [8].
These ﬁndings suggest the possibility that tyrosine
phosphatase activity may be of signiﬁcant importance in
the regulation of crypt cell proliferation. Secondly, as the
extracellulardomainofLARhashomologywithadhesion
molecules, the ﬁnding of this molecule on IEL could sug-
gestapossiblefunctionalroleinmigrationandhomingof





Figure 4. Immunohistochemistry of LAR staining on duodenal biopsy tissue. (a) Duodenal biopsy tissue stained with anti-LAR at
magniﬁcation of ×200. The positive staining is brown and the presence of IEL with weak staining is indicated by black arrows. (b)
Note: LAR expression in intraepithelial lymphocytes at the tips of the villi is very low (indicated by a black arrow). (c) Staining is
stronger in the IEL within the lower third of the crypt (indicated by a black arrow). (d) Staining of positive control HUVECs with
anti-LAR antibody. (e) Staining of duodenal biopsy tissue with anti-KLH, negative control.2005:1 (2005) Tyrosine Phosphatase Expression in the Human Duodenum 29
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